Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Gastroenterology | Endocrinology
Clinical Trials: Pancreatic Cancer
A listing of clinical trials currently looking for volunteers to enroll in Pancreatic Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : UAB Comprehensive Cancer Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Birmingham : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Huntsville : Clearview Cancer Institute Oncology Specialties, P.C
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Birmingham : Birmingham Hematology and Oncology Associates, LLC
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Birmingham : University of Alabama Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Mobile : University of South Alabama Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Muscle Shoals : Northwest Alabama Cancer Center Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Arizona
Scottsdale : Mayo Clinic Arizona
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Scottsdale : Scottsdale Med Specialist TGen Clinical Research Services
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Tucson : AZ Cancer Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Scottsdale : TGen Clinical Reserch Services at Scottsdale Healthcare
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Tucson : Arizona Cancer Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Arkansas
Hot Springs : Genesis Cancer Ctr - Hot Springs
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Little Rock : University of Arkansas for Medical Sciences Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
California
Bellflower : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Beverly Hills : Tower Cancer Research Foundation
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Duarte : City of Hope Updated New
A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreas (algenpantucel-L) immunotherapy in Subjects with Surgically Resected Pancreatic Cancer
Duarte : City of Hope Comprehensive Cancer Care Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Duarte : City of Hope Updated
Clinical Value of Molecular Profiling of Pancreatic Cancer Surgical Patients
Duarte : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Duarte : City of Hope Updated New
Phase 2 Placebo-Controlled Double-Blind Trial of Dasatinib Added to Gemcitabine for Subjects with Locally-Advanced Pancreatic Cancer
Encinitas : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Long Beach : Pacific Shores Medical Group
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Los Angeles : William H. Isacoff, MD, Inc.
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Los Angeles : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Orange : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Rancho Mirage : Desert Hem/Onc Medical Group
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
San Francisco : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Santa Maria : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Alhambra : Central Hematology Oncology Medical Group, Inc.
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Anaheim : Pacific Cancer Medical Center
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Bakersfield : Comprehensive Blood and Cancer Center
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Duarte : City of Hope National Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Fresno : Cancer Care Associates of Fresno Medical Group, Inc.
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Fullerton : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
La Jolla : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Long Beach : Pacific Shores Medical Group
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Los Angeles : UCLA Community Oncology Practice
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Los Angeles : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Los Angeles : Cedars-Sinai Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Los Angeles : University of Southern California Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Palo Alto : Stanford Cancer Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Rancho Mirage : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Redondo Beach : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
San Francisco : California Pacific Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Santa Maria : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Colorado
Aurora : Univ of Colorado Cancer Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Aurora : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Aurora :
A Study of DMOT4039A in Patients With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Aurora : University of Colorado Denver
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Aurora : University of Colorado Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Grand Junction : Saint Mary's Regional Cancer Center
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Connecticut
Stamford : Stamford Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Delaware
Newark : Christiana Care Health Services Helen Graham Cancer Center
A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Florida
Boynton Beach : University Cancer Institute, LLC
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Boynton Beach : Collaborative Research Group
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Boynton Beach : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Ft Myers : FL Cancer Spec
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Lakeland : Lakeland Regional Cancer Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Orlando : FL Hospital Cancer Institute
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Tampa : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Tavares : Lake County Onc & Hem FL Hosp Waterman
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Boca Raton : Boca Raton Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Ft. Lauderdale : Broward Oncology Associates Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Gainesville : University of Florida Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Jacksonville : Mayo Clinic Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Jacksonville : Baptist Cancer Institute Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
New Port Richey : Pasco Pinellas Cancer Center Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Tampa : MOFFITT Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Tampa : H. Lee Moffitt Cancer Center and Research Institute
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
Tampa : Tampa General Hospital Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Tampa : H. Lee Moffitt Cancer Center and Research Institute
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
Titusville : Space Coast Medical Associates
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Georgia
Athens : Northeast GA Cancer Care
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Atlanta : Piedmont Hospital Research Institute
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Atlanta : Georgia Cancer Specialist
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Atlanta : Atlanta Cancer Care
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Atlanta : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Savannah : Memorial Health University Medical Center
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Savannah : Memorial Health University Medical Center
Gemcitabine and Erlotinib With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery SWOG S0727
Savannah : Memorial Health University Medical Center
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By Chemotherapy With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery RTOG 0848
View More »
Atlanta : Georgia Cancer Specialists, P.C.
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Illinois
Arlington Heights : Cancer Care & Hem Spec of Chicagoland
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Chicago : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Peoria : IL Cancer Care, PC
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Arlington Heights : Illinois Cancer Specialists Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Chicago : University of Chicago Medical Center
Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer
Chicago : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Chicago : Northwestern University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Evanston : Northshore University Health Systems Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Galesburg : Medical and Surgical Specialists Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Harvey : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Quincy : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Skokie : Hematology / Oncology of the North Shore Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Indiana
Indianapolis : IN Univ Simon Cancer Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Indianapolis : Indiana University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Indianapolis : Investigative Clinical Research of Indiana, LLC Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Indianapolis : Investigative Clinical Research of Indiana
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Iowa
Ames : McFarland Clinic Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Iowa City : University of Iowa Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Kansas
Wichita : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Kentucky
Louisville : Owsley Brown Frazier Cancer Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Hazard : Kenthucky Cancer Clinic
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Louisville : University of Louisville Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Louisiana
Baton Rouge : Hematology-Oncology Clinic
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Baton Rouge : Mary Bird Perkins Cancer Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Baton Rouge : Mary Bird Perkins Cancer Center Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
New Orleans : Ochsner Cancer Institute Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Maine
Scarborough : ME Ctr for Cancer Medicine and Blood Disorders
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Maryland
Baltimore : Sidney Kimmel Comp Cancer Ctr at Johns Hopkins
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Bethesda : Ctr for Cancer & Blood Disorders - MD
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tarceva With Chemoradiation and Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Bethesda : National Cacner Institue
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Bethesda : National Cancer Institute
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Massachusetts
Burlington : Lahey Clinic
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Worcester : Cancer Ctr of Excellence - Univ of MA Med School
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Boston : Novartis Investigative Site
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
Boston : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Boston : Beth Israel Deaconess Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Boston : Dana-Farber Cancer Institute Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Boston : Massachusetts General Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Boston : Dana-Farber Cancer Institute
Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin
Boston : Massachusetts General Hospital Cancer Center
Safety Study of MGA271 in Refractory Cancer
Burlington : Lahey Clinic Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Michigan
Detroit : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Detroit : Henry Ford Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Detroit : Karmanos Cancer Institute
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Grand Rapids : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kalamazoo : West Michigan Cancer Center
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
View More »
Royal Oak : Beaumont Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Minnesota
Minneapolis : Univ of MN
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Minneapolis : Virginia Piper Cancer Institute MN Onc Hem, PA
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Minneapolis : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Minneapolis : Virginia Piper Cancer Institute Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Rochester : Mayo Clinic Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
St. Louis Park : Park Nicollet Institute
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Mississippi
Tupelo : Hematology and Oncology Associates at BridgePoint
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Missouri
Springfield : St John's Med Res Inst
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Columbia : University of Missouri Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Kansas City : Research Medical Center Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
St. Louis : Washington University School of Medicine
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
St. Louis : Washington University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Montana
Missoula : Montana Cancer Institute Foundation c/o Montana Cancer Specialists
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Nebraska
Omaha : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Omaha : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Lincoln : Southeast Nebraska Hematology & Oncology Consultants Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Omaha : University of Nebraska Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Nevada
Henderson : Comprehensive Cancer Centers of Nevada
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
New Mexico
Albuquerque : Univ of NM
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Albuquerque : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research Updated New
A Phase 2 Study of REOLYSIN in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Bronx : Biomedical Research Alliance of New York
Pancreatic Cancer - Adults
Buffalo : Roswell Park Cancer Institute
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Lake Success : Arena Onc Associates
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Lake Success : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Lake Success : Biomedical Research Alliance of New York
Pancreatic Cancer
Syracuse : SUNY Upstate Medical University
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Syracuse : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Lake Success : Arena Oncology Associates Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
New York : Beth Israel Comprehensive Cancer Center
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
New York : Herbert Irving Comprehensive Cancer Center of Columbia University
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
New York : Mount Sinai Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
New York : Memorial Sloan Kettering Cancer Center
Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess
New York : Beth Israel Cancer Center
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Rochester : University of Rochester
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Staten Island : Richmond University Medical Center Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
North Carolina
Charlotte : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Winston Salem : Piedmont Hem Onc Assoc, PLLC
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Durham : Duke University Medical Center
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Durham : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Durham : Duke University Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
High Point : Emerywood Hematology and Oncology
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Winston-Salem : Wake Forest Baptist Health Comprehensive Cancer Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Ohio
Cincinnati : Oncology Hematology Care
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Columbus : dba The Mark H. Zangmeister Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Middletown : Signal Point Clinical Research Center, LLC
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Akron : Summa Health System
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Canton : Gabrail Cancer Center Research
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Cincinnati : University of Cincinnati Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Cleveland : University Hospitals Case Western Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Cleveland : University Hospitals
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
Columbus : Ohio State University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Oklahoma
Lawton : Cancer Ctrs of Southwest Okahoma Research
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Oklahoma City : Cancer Care Associates - Mercy, Oklahoma City
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Oklahoma City : Univ of OK Health Sciences Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Tulsa : Cancer Care Associates - Tulsa
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Oklahoma City : University of Oklahoma Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Oklahoma City : University of Oklahoma Health Sciences Center
Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
Oregon
Bend : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Portland : Providence Portland Medical Center
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Portland : Oregon Health and Science University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Pennsylvania
Bethlehem : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Langhorne : St. Mary Medical Center Hematology-Oncology Group, PC
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Pittsburgh : Univ of Pittsburgh Med Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Dunmore : Hematology and Oncology Associates of NE PA Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Gettysburg : Gettysburg Cancer Center
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Hershey : Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer
Hershey : Penn State Hershey Cancer Institute Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Philadelphia : University of Pennsylvania Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Philadelphia : Fox Chase Cancer Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Philadelphia : Thomas Jefferson University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center
Safety Study of MGA271 in Refractory Cancer
Pittsburg : University of Pittsburg Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Rhode Island
Providence : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Providence : Roger Williams Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
South Carolina
Charleston : Charleston Hematology Oncology Associates, PA
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Charleston : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Charleston : Charleston Hematology Oncology Associates
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Columbia : South Carolina Oncology Associates
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Hilton Head : South Carolina Cancer Specialists, PA
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Tennessee
Chattanooga : Chattanooga Oncology Hematology Care
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Nashville : Tennessee Oncology
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Chattanooga : Associates in Oncology and Hematology
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Knoxville : Tennessee Cancer Specialists
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Knoxville : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Memphis : The West Clinic Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Nashville : Vanderbilt University
IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Nashville : Sarah Cannon Research Institute
Safety Study of MGA271 in Refractory Cancer
Texas
Houston : S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Pancreas
San Antonio : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Corpus Christi : Coastal Bend Cancer Center
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Dallas : University of Texas Southwestern Medical Center Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Dallas : Mary Crowley Cancer Research Centers (MCCRC)
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Dallas : Sammons Cancer Center
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Fort Worth : Center for Cancer and Blood Disorders, PC
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Houston : UT MD Anderson Cancer Center Updated
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Houston : UT MD Anderson Cancer Center
Chemoradiation-Induced Nausea and Emesis: Quality of Life
Houston : UT MD Anderson Cancer Center
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
Houston : Ben Taub Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Houston : Baylor College of Medicine Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Houston : The Methodist Hospital Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Houston : Oncology Consultants Updated
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Lubbock : Joe Arrington Cancer Research and Treatment Center
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Paris : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
San Antonio : University of Texas Health Sciences Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
San Antonio : South Texas Accelerated Research Therapeutics (START)
Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Utah
Salt Lake City : Huntsman Cancer Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Salt Lake City : Novartis Investigative Site
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
Vermont
Burlington : University of Vermont/Vermont Cancer Center
Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine
Virginia
Richmond : VA Cancer Inst
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Charlottesville : University of Virginia Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Fairfax : Virginia Cancer Specialists, PC
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Lynchburg : Lynchburg Hematology-Oncology Clinic, Inc. Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Richmond : Virginia Cancer Institute
A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
Richmond : Virginia Commonwealth University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Washington
Seattle : Fred Hutchinson Cancer Research Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Seattle : Swedish Cancer Inst
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Seattle : Virginia Mason Medical Center
Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
Seattle : University of Washington- Seattle Cancer Center Alliance Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Spokane Valley : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
West Virginia
Morgantown : West Virginia University - Clinical Trials Research Unit
ACOSOG-Z5041: Ph2 of Neoadjuvant and Adjuvant Gemcitabine Hydrochloride and Erlotinib Hydrochloride in pts + Resectable Adenocarcinoma of the Pancreas Undergoing Pancreatectomy.
Wisconsin
Milwaukee : Med College of WI Froedtert Multi-Disciplinary Cancer Clinic
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Madison : University of Wisconsin Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Australia
Bankstown, NSW : Bankstown-Lidcombe Hosp
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Bedford Park, SA : Department of Medical Oncology
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Bendigo , VIC : Bendigo Hosp
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Blacktown : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Campbelltown, NSW : Macarthur Cancer Therapy Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Concord, NSW : Sydney Cancer Centre
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Darlinghurst, NSW : St. Vincent's Hospital- Sydney Medical Oncology Department
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
East Bentleigh, VIC : Oncology Research Unit
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Footscray : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Footscray, VIC : Oncology Research
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Frankston, VIC : Peninsula Oncology Centre Frankston Private
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Frankston, VIC : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Herston, QLD : Royal Brisbane and Women's Hospital
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Hobart, TAS : Royal Hobart Hospital
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kurralta Park, SA : Adelaide Cancer Centre (T/A Ashford Cancer Ctr)
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Liverpool : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Melbourne, VIC : Alfred Hospital
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Nedlands, WA : Sir Charles Gairdner Hospital
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
North Adelaide , South Australia : Calvary North Adelaide Hospital
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Parkville : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Randwick, NSW : Prince of Wales Hosp
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
South Brisbane, QLD : Mater Private Medical Centre Haematology & Oncology Clinics of Australasia Research Centre
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Southport, Gold Coast, QLD : HOCA Gold Coast Cancer Centre
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Tweed Heads : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Waratah, NDW : Newcastle Calvary Mater Hospital
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Wodonga, VIC : Border Med Onc
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Wollongong, NSW : Southern Medical Day Care Centre
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Adelaide : Royal Adelaide Hospital
Proteasome Inhibitor NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
Bentleigh East : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Box Hill : Box Hill Hospital
A Study of Gemcitabine Plus OMP-21M18 as 1st-line Treatment in Subjects With Pancreatic Cancer
Camperdown : Royal Prince Alfred Hospital
A Study of Gemcitabine Plus OMP-21M18 as 1st-line Treatment in Subjects With Pancreatic Cancer
Heidelberg : The Austin Hospital
A Study of Gemcitabine Plus OMP-21M18 as 1st-line Treatment in Subjects With Pancreatic Cancer
Kogarah : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kurralta Park : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nedlands : Sir Charles Gairdner Hospital and University of Western Australia
Proteasome Inhibitor NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
Parkville : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
South Brisbane : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Woodville South : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Woodville South : The Queen Elizabeth Hospital
Proteasome Inhibitor NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
Austria
Graz : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Innsbruck : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Wien : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Innsbruck : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salzburg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Steyr : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Wien :
ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
Wien : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Belgium
Brussels : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Leuven : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Bruxelles : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Charleroi : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Edegem : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gent : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leuven : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Libramont : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Brazil
Curitba : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Curitba : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
ItajaÃ- : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Itajaí : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto Alegre : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Porto Alegre : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
São Paulo : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salvador : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Canada
Barrie, ON : Royal Victoria Hospital, Barrie
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Calgary, AB : Tom Baker Cancer Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Montreal, QC : Hopital du Sacre-Coeur de Montreal
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Montreal, Quebec : Centre Hospitalier de L'Universite de Montreal St-Luc
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Quebec : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Quebec, QC : CHUQ - Hotel-Dieu de Quebec
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Toronto : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Toronto, ON : Princess Margaret Hosp
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Vancouver, BC : BC Cancer Agency- Vancouver
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
View More »
Oshawa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ottawa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Quebec : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Toronto : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vancouver : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
China
Shanghai : Shanghai Changhai Hospital
Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer
Tianjin : Tianjin Medical University Cancer Institute and Hospital
Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure
Czech Republic
Olomouc : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Pardubice : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Prague 8 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Zlin : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Brno : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hradec Kralove : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Olomouc : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 2 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 5 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Denmark
Aalborg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Herlev : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Odense : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Finland
HUS : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lahti : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tampere : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Turku : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
France
Angers : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Besançon cedex : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Clermont Ferrand cedex 1 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Clichy : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Lille : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Lyon cedex 03 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Paris cedex 14 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Saint-Priest-en-Jarez : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Saint-Priest-en-Jarez cedex 2 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Besançon Cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Besançon Cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Brest cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Clermont Ferrand Cedex 1 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Pessac Cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Germany
Bochum : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Hamburg : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Hamburg : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Jena : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Köln : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Köln : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Lemgo : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Mannheim : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
München : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Tübingen : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Berlin : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Dresden : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Halle (Saale) : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Münster : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mainz : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mannheim : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Marburg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Münster : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Villingen-Schwenningen : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Greece
Athens : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Heraklion : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Patra : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Thessaloniki : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hong Kong
Kowloon : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sha Tin : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tuen Mun : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hungary
Budapest : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Budapest : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Gyor : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Pecs : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Budapest : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Debrecen : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gyor : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Miskolc : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ireland
Dublin 24 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Dublin 4 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Dublin 7 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Dublin 9 : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Israel
Jerusalem : Hadassah Medical Organization
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Operable Adenocarcinoma of the Pancreas
Ramat Gan : Sheba Medical Center
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Operable Adenocarcinoma of the Pancreas
Italy
Ancona : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Milan : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Reggio Emilia : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Bologna : Azienda Ospedaliero-Universitaria di Bologna
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Brescia : Fondazione Poliambulanza
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Genova : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Messina : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Monza : Azienda Ospedaliera San Gerardo Struttura Complessa Oncologia Medica
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Napoli : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Novara : AOU Maggiore della Carità
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
San Giovanni Rotondo (FG) : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Japan
Gifu : Gifu University
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Kashiwa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mitaka-city : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nagoya-city : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Onomichi : Onomichi General Hospital
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
View More »
Sapporo : Teine-Keijinkai Hospital
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Sunto-gun : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tokyo : The University of Tokyo
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Tokyo : Toho University
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Tokyo : Tokyo Medical University
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Tokyo : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ube : Yamaguchi University
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Yokohama-city : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Korea, Republic of
Bucheon : Soon Chun Hyang University School of Medicine
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Cheonan : Soon Chun Hyang University School of Medicine
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Daegu : Catholic University of Daegu School of Medicine
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Goyang-si : NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong‐gu,
Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)
Incheon : Inha University School of Medicine
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
View More »
Seoul : Gangnam Severance Hospital
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Seoul : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Suwon : Ajou University School of Medicine
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Lithuania
Kaunas : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vilnius : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Netherlands
Amsterdam : VU University Medical Center
Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Amsterdam : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Eindhoven : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Groningen : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leiden : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
New Zealand
Christchurch : Christchurch Hospital
A Study of Gemcitabine Plus OMP-21M18 as 1st-line Treatment in Subjects With Pancreatic Cancer
Hamilton : Waikato Hospital
A Study of Gemcitabine Plus OMP-21M18 as 1st-line Treatment in Subjects With Pancreatic Cancer
Poland
Lublin : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Olsztyn : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Gdansk : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Konin : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lodz : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poznan : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Warszawa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Portugal
Barreiro : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lisboa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Romania
Cluj Napoca : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cluj-Napoca : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Russia
Barnaul : Altai Territorial Oncological Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Chelyabinsk : Chelyabinsk Regional Oncol Ctr Chemotherapy Department
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Chelyabinsk : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Ivanovo : Ivanovo Regional Oncology Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kazan : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Kazan, Republic of Tatarstan : Tatarstan Republican Onc Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Krasnodar : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Magnitogorsk : Regional Oncological Center # 2
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Central Clinical Hospital of the President of the Russian Federation, Oncology Department
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Blokhin Cancer Research Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Non State Medical Institution: Central Clinical Hospital #2 n.a. Semashko
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Russian Res Ctr of Radiology under the Fed Agency for Hi-Tech Med Care
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Russian Research Ctr of Surgery n.a. B.V. Petrovskiy under the Russian Academy of Med Sciences
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Moscow City Clinicall Hospital #57 Chemotherapy Dept.
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Moscow : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Moscow Region, Moscow : Moscow Municipal Onc Hosp #62
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Obninsk, Kaluga Region : Med Radiological Res Ctr under the Russian Academy of Med Sciences
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Omsk : Omsk Regional Onc Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Orenburg : Orenburg Regional Oncology Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Pyatigorsk : Pyatigorsk Affiliate of Stavropol Regional Oncology Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
St. Petersburg : Russian Research Ctr for Radiology and Surgical Technologies
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
St. Petersburg : State Med Inst: St. Petersburg City Oncology Center, Chemotherapy Dept
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
St. Petersburg : St. Petersburg State Med Academy n.a.Mechnikov
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
St. Petersburg : Clinical Hosp # 122 n.a. L.G. Sokolowv
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
St. Petersburg : Leningrad Regional Clinical Hosp
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Tula : Tula Regional Oncology Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Ufa : Bashkortostan Republican Oncology Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Yaroslavl : Yaroslavl Regional Oncology Center Chemotherapy Department
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Russian Federation
Chelyabinsk : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Moscow : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Saint Petersburg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Samara : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Saudi Arabia
Riyadh : National Guard Health Affairs
Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer
Serbia
Belgrade : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sremska Kamenica : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Singapore
Outram Road : Singapore General Hospital
32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer
Slovakia
Bardejov : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bratislava : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kosice : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nitra : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poprad : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Slovenia
Ljubljana : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Spain
A Coruña : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
A Coruña : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Alicante : Hospital General de Alicante
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Badalona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Badalona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Barcelona : Novartis Investigative Site
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
Barcelona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Barcelona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Elche : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Elche : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Madrid : START Madrid
A Study of Gemcitabine Plus OMP-21M18 as 1st-line Treatment in Subjects With Pancreatic Cancer
Madrid : Hospital Gregorio Marañon
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Madrid : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santander : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sevilla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Valencia : Instituto Valenciano de Oncologia
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Valencia : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Zaragoza : Hospital Miguel Servet
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Sweden
Eskilstuna : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linköping : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linköping : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Uppsala : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Switzerland
Basel : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Geneva 14 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Winterthur : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taiwan
Gueishan Township : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Niaosong Township : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taipei City : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ukraine
Dnepropetrovsk : Dnepropetrovsk State Med Academy, Onc Dept at City Clinical Hospital #4
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Donetsk : Donetsk Regional Antitumor Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kharkiv : Kharkiv Regional Onc Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kharkov : Kharkov Regional Onc Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kherson : Kherson Regional Oncology Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kirovohrad : Kirovohrad Regional Oncology Center, Department of Chemotherapy
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kyiv : National Institute of Cancer, Department of Tumors of Abdominal Cavity and Retroperitoneum
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Kyiv : Kyiv City Clinical Hospital #10, Center for Hepatic, Bile Duct and Pancreatic Surgery
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Lutsk : Volyn Regional Oncology Center, Department of Oncochemotherapy
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Lviv : Lviv State Regional Treatment and Diagnostics Onc Ctr
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Odesa : Odessa Regional Clinical Hospital, Department of General Surgery
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Zaporizhia : Zaporizhia Medical Academy of Postgraduate Education
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Zhytomyr : O.F. Herbachevskyi Regional Clinical Hospital, Surgery Center
A Randomized Phase 3 Study of Abraxane (ABI-007) Plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
United Kingdom
Chelmsford, Essex : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Edinburgh : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Glasgow : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Hull : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Leeds : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Liverpool : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
London : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
London : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Maidstone : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Northwood : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Salisbury : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
Sutton : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
View More »
Belfast : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Birmingham : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bournemouth : The Royal Bournemouth Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Bradford : Bradford Royal Infirmary
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Cambridge : Cambridge University Hospitals NHS Foundation Trust
HYPAZ: Hypertension Induced by Pazopanib
Cardiff : Velindre Cancer Centre
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Cottingham : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Guildford : Royal Surrey County Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Leicester : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Liverpool : Clatterbridge Centre for Oncology Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Liverpool : Royal Liverpool University Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Liverpool : Novartis Investigative Site
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
London : Guy's and St Thomas' Hospital NHS Trust
32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer
London : The London Clinic Cancer Centre
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
London : Guys & St Thomas Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Manchester : The Christie Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Manchester : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Middlesbrough : James Cook University Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Northampton : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nottingham : Nottingham City Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Peterborough : Peterbrough City Hospital, Haematology/Oncology Dept,
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Sheffield : Weston Park Hospital Updated
Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Skipton : Airedale General Hospital
A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Sutton : The Royal Marsden NHS Trust
A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)
United States
Washington : Georgetown University Updated
Immunotherapy Study for Surgically Resected Pancreatic Cancer
USA
Liverpool : Research Site
Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (LAPC)
